We hypothesized that elevated levels of ET-1 would be associated with higher pulmonary artery pressures, and more specifically, PAH, among HIV-infected individuals and would provide additional support for ET-1 mediated endothelial dysfunction as an important mechanism underlying HIV-associated PAH. Here, EDN1 is linked to pulmonary arterial hypertension.